How big is the Global HLA Typing Market?

The Global HLA Typing Market size is expected to reach USD 0.75 billion in 2024 and grow at a CAGR of 7.15% to reach USD 1.06 billion by 2029. Read More

What is the current Global HLA Typing Market size?

In 2024, the Global HLA Typing Market size is expected to reach USD 0.75 billion. Read More

Who are the key players in Global HLA Typing Market?

Illumina, Inc., Qiagen, Thermofisher Scientific, Inc., Omixon, Inc. and Becton, Dickinson and Company are the major companies operating in the Global HLA Typing Market. Read More

Which is the fastest growing region in Global HLA Typing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global HLA Typing Market?

In 2024, the North America accounts for the largest market share in Global HLA Typing Market. Read More

What years does this Global HLA Typing Market cover, and what was the market size in 2023?

In 2023, the Global HLA Typing Market size was estimated at USD 0.70 billion. The report covers the Global HLA Typing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global HLA Typing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global HLA Typing Market Share

Statistics for the 2023 & 2024 Global HLA Typing market share, created by Mordor Intelligence™ Industry Reports. Global HLA Typing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global HLA Typing Industry

The market for HLA typing market is slightly fragmented due to the rise in the number of product launches by many biotechnological companies, the rise in innovative biotechnological companies, rise in genetic testing, among others. Some of the key players that are expected to dominate the HLA Typing market include Thermofisher Scientific Inc., Qiagen, Illumina Inc., F. Hoffman-La Roche Limited, Bio-Rad Laboratories Inc., Beckton, Dickinson and Company, TBG Diagnostics Ltd, Takara Bio Inc., GenDX, and Omixon Inc, among others.